Fortress Biotech (FBIOP) Competitors $6.61 -0.02 (-0.30%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$6.62 +0.01 (+0.15%) As of 05/2/2025 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock FBIOP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Fortress Biotech vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Fortress Biotech (NASDAQ:FBIOP) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations. Is FBIOP or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Fortress BiotechN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community believe in FBIOP or ATNFW? Fortress Biotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformFortress BiotechN/AN/A180 Life SciencesN/AN/A Which has preferable valuation & earnings, FBIOP or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$57.68MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to FBIOP or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Fortress Biotech. 180 Life Sciences' average media sentiment score of 0.59 beat Fortress Biotech's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Fortress Biotech Neutral 180 Life Sciences Positive Summary180 Life Sciences beats Fortress Biotech on 2 of the 3 factors compared between the two stocks. Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBIOP vs. The Competition Export to ExcelMetricFortress BiotechBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$125.50M$5.55B$8.03BDividend Yield12.11%3.69%5.09%4.23%P/E RatioN/A3.2722.7118.85Price / SalesN/A4,272.58405.27106.76Price / CashN/A13.0238.1834.62Price / BookN/A34.206.794.33Net IncomeN/A-$90.45M$3.22B$248.06M7 Day Performance-1.34%1.35%3.33%3.18%1 Month Performance15.76%5.29%6.89%8.26%1 Year Performance-58.53%92.74%16.07%4.99% Fortress Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBIOPFortress BiotechN/A$6.61-0.3%N/A-57.7%$0.00$57.68M0.00170ATNFW180 Life SciencesN/A$0.01-4.2%N/A-14.1%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01-10.0%N/A-78.0%$0.00N/A0.002AIMDWAinosN/A$0.10-5.9%N/AN/A$0.00$20,729.000.0040Positive NewsALVOWAlvotechN/A$1.28-7.9%N/A-65.4%$0.00$489.68M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-78.8%$0.00N/A0.0015BFRIWBiofronteraN/A$0.05flatN/A-33.3%$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.02-5.1%N/AN/A$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12-9.6%N/A-86.4%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.04-8.5%N/AN/A$0.00$48.20M0.00220Positive News Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBIOP) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
